Immune response during lactation after anti-SARS-CoV2 mRNA vaccine
Yarden Golan(Cornell University), Stephanie L. Gaw(University of California, San Francisco), Mary Prahl(University of California, San Francisco), Valerie J. Flaherman(University of California, San Francisco), Emilia Basilio(University of California, San Francisco), Ifeyinwa V. Asiodu(Health Care Foundation), Lakshmi Warrier(University of California, San Francisco), Christine Y. Lin(Society for Maternal-Fetal Medicine), Alan H.B. Wu(University of California, San Francisco), Arianna G. Cassidy(University of California, San Francisco), Nadav Ahituv(University of California, San Francisco), Sirirak Buarpung(University of California, San Francisco), Veronica J. Gonzalez(University of California, San Francisco), Unurzul Jigmeddagva(Reproductive Science Center)
Unknown
March 12, 2021
Cited by 3
Related Papers
Update: Interim Guidance for the Diagnosis, Evaluation, and Management of Infants with Possible Congenital Zika Virus Infection — United States, October 2017
|MMWR Morbidity and Mortality Weekly Report|2017|218
Circulating Brain-Derived Neurotrophic Factor Has Diagnostic and Prognostic Value in Traumatic Brain Injury
|Journal of Neurotrauma|2015|152
Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity
|Science Translational Medicine|2022|139
Circulating Angiogenic Factor Levels in Hypertensive Disorders of Pregnancy
|NEJM Evidence|2022|130